Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 51 subunit beta | 0.780 | 0.077 | 0.24 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
glyoxalase domain containing 4 | 1.000 | 0.077 | 6.1E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
sphingomyelin phosphodiesterase acid like 3B | 0.861 | 0.192 | 2.4E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
solute carrier family 51 subunit alpha | 0.792 | 0.231 | 7.0E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
microRNA let-7a-3 | 0.751 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
solute carrier family 9 member C1 | 0.780 | 0.308 | 3.0E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
transmembrane protein 132A | 0.792 | 0.308 | 2.0E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
glutamine-fructose-6-phosphate transaminase 2 | 0.769 | 0.308 | 6.4E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
fructosamine 3 kinase | 0.769 | 0.346 | 2.1E-08 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2018 | ||||||||
|
myo-inositol oxygenase | 0.760 | 0.346 | 1.1E-17 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2011 | ||||||||
|
microRNA 3188 | 0.769 | 0.346 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
WAS/WASL interacting protein family member 2 | 0.760 | 0.385 | 0.19 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
paired box 4 | 0.644 | 0.423 | 4.2E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
KMT5A pseudogene 1 | 0.716 | 0.423 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
angiogenic factor with G-patch and FHA domains 1 | 0.650 | 0.462 | 2.7E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
diabetic nephropathy | 0.678 | 0.500 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2011 | 2019 | |||||||||
|
SOD2 overlapping transcript 1 | 0.722 | 0.500 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
protein kinase C substrate 80K-H | 0.674 | 0.538 | 1.0E-07 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2010 | ||||||||
|
peptidase domain containing associated with muscle regeneration 1 | 0.760 | 0.538 | 6.3E-32 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
SHC adaptor protein 1 | 0.597 | 0.538 | 1.7E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
solute carrier family 10 member 2 | 0.621 | 0.538 | 9.6E-17 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
carnosine dipeptidase 1 | 0.656 | 0.538 | 1.2E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
long intergenic non-protein coding RNA, p53 induced transcript | 0.663 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
small ubiquitin like modifier 4 | 0.653 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 1 | 2008 | 2008 | |||||||||
|
denticleless E3 ubiquitin protein ligase homolog | 0.650 | 0.577 | 3.3E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |